Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02592291 · ClinicalTrials.gov registry record · NA
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
A NA study of Spinal Cord Injuries and Traumatic Brain Injury, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT02592291: Recruiting NA study of Spinal Cord Injuries and Traumatic Brain Injury, sponsored by University of Pittsburgh.
NCT02592291 is a NA study of Spinal Cord Injuries and Traumatic Brain Injury that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 160 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (162% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02592291, a NA study of Spinal Cord Injuries and Traumatic Brain Injury, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the benefits of using mobile health system designed for individuals with chronic and complex health conditions (such as those with Spinal Cord Injury,Cerebral Palsy, Spina Bifida, and Traumatic Brain Injury) to improve their wellness and self-management skills compared to those who receive standard of care only.
Primary Outcome
Self management skill ratings measured at baseline, and approximately every three months for up to 12 months.
Conditions Studied
Interventions
- DEVICE MHealth
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT02592291 shows while recruiting
NCT02592291 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (162% higher).
The record links to 6 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which MHealth is the first listed.
NCT02592291 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02592291 about?
NCT02592291 is a clinical study titled "Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions". This study will assess the benefits of using mobile health system designed for individuals with chronic and complex health conditions (such as those with Spinal Cord Injury,Cerebral Palsy, Spina Bifida, and Traumatic Brain Injury) to improve their wellness and self-management skills compared to thos...
What is the current status of trial NCT02592291?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2019-10-01. Estimated completion is 2026-09.
What conditions does trial NCT02592291 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Traumatic Brain Injury, Cerebral Palsy, Brain Injuries, Spina Bifida.
What interventions are being tested in trial NCT02592291?
The interventions under investigation include: MHealth (DEVICE).
Who is sponsoring clinical trial NCT02592291?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02592291 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02592291's enrollment target sits among peer trials
160 17th of 202 higher than 184 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy